The U.S. Food and Drug Administration today approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to reduce severe complications associated with the blood...

Data from 77 countries show that antibiotic resistance is making gonorrhea – a common sexually-transmitted infection – much harder, and sometimes impossible, to treat, according to a World Health Organization...

New multicenter research, which included Vanderbilt University Medical Center investigators, could change treatment approaches to simple skin abscesses, infections often caused by Staphylococcus aureus (staph)...

A multi-institutional team of investigators reported this week in Science Translational Medicine on a new antiviral drug candidate that inhibits a broad range of coronaviruses, including the SARS and...

Orlando-based specialty pharmaceutical company, Profounda announced it has received the US Food and Drug Administration’s Orphan Drug Designation for the use of Impavido (miltefosine) to treat Granulomatous...

A new study suggests that most people with acute conjunctivitis, or pinkeye, are getting the wrong treatment. About 60 percent of patients nationwide are prescribed antibiotic eye drops, even though antibiotics...

Melinta Therapeutics announced Monday that the U.S. Food and Drug Administration (FDA) has approved Baxdela™ (delafloxacin), indicated in adults for the treatment of acute bacterial skin and skin structure...

Scientists from Rutgers University-New Brunswick, the biotechnology company NAICONS Srl., and elsewhere have discovered a new antibiotic effective against drug-resistant bacteria: pseudouridimycin. The...

To win the war against antibiotic resistant super bugs, scientists seek to find the origin of resistance genes. Further, they try to identify how the genes are introduced to disease-causing bacteria –...

GlaxoSmithKline (GSK) and Medicines for Malaria Venture (MMV) today announced positive results from two phase III studies of tafenoquine, an investigational 8-aminoquinoline, for the prevention of relapse...